Develop an integrated model of anhedonic depression capturing both internal biological factors and externally-manifested and quantifiable symptom-correlated biometrics and behavioral measures. This model should stratify people into those who will be treatment sensitive and those who will be treatment resistant with 80% accuracy, consistent with the current 20% false negative rate for mammograms.